Patients should not attempt to source retatrutide outside of approved clinical trials
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UKBM
Instead, it underscores the need for a comprehensive approach to treatment, one that involves monitoring for potential side effects and addressing them proactively
Lancet 397(10278):971984 Gerstein HC, Colhoun HM, Dagenais GR et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
On top of this, some treatments are believed to boost blood circulation in the scalp and strengthen existing hair, potentially leading to improved hair density and texture
Beyond pancreatic effects, semaglutide slows gastric emptying, which moderates postprandial glucose excursions and promotes satiety